Name | 1-((2S,3R,4S,5S)-3-Fluoro-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-5-methylpyrimidine-2,4(1H,3H)-dione |
---|---|
Synonyms |
CLEVUDINE
Clevudine Levovir L-FMAU |
Description | Clevudine is an antiviral drug for the treatment of hepatitis B. Target: HBVClevudine is a nucleoside analog with an unnatural beta-L configuration. Clevudine showed potent antiviral activity during therapy and induced a sustained posttreatment antiviral effect for 6 months after a 12-week treatment period, and this was associated with a sustained normalization of ALT levels [1]. Clevudine showed a potent antiviral response, and its effect was higher in HBeAg-negative patients, with rapid viral load reduction after therapy. However, long-term therapy for more than 1 year resulted in the development of considerable resistance and myopathy. Therefore, we should consider alternative antiviral agents if clevudine resistance or clevudine-induced myopathy is developed in patients on clevudine for the treatment of CHB [2]. |
---|---|
Related Catalog | |
References |
Density | 1.55g/cm3 |
---|---|
Melting Point | 184-185° |
Molecular Formula | C10H13FN2O5 |
Molecular Weight | 260.21900 |
Exact Mass | 260.08100 |
PSA | 104.55000 |
Index of Refraction | 1.592 |
Storage condition | -20°C |
Hazard Codes | Xi |
---|---|
HS Code | 2934999090 |
HS Code | 2934999090 |
---|---|
Summary | 2934999090. other heterocyclic compounds. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |